Richtig G, Wolf M, Schulter G, et al. Body-Mass-Index as a predictive marker for response in patients with metastatic melanoma treated with ipilimumab. SMR 2017, P01-15.
Brigatinib bij crizotinib-refractair ALK-positief NSCLC
jun 2017 | Longoncologie